These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 19928052)
1. [Molecular descriptors of amino acids for the evaluation of the physicochemical parameters and biological activity of peptides]. Tiunina EIu; Badelin VG Bioorg Khim; 2009; 35(4):501-9. PubMed ID: 19928052 [TBL] [Abstract][Full Text] [Related]
2. QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors. Wang X; Wang J; Lin Y; Ding Y; Wang Y; Cheng X; Lin Z J Mol Model; 2011 Jul; 17(7):1599-606. PubMed ID: 20941517 [TBL] [Abstract][Full Text] [Related]
3. A new set of amino acid descriptors and its application in peptide QSARs. Mei H; Liao ZH; Zhou Y; Li SZ Biopolymers; 2005; 80(6):775-86. PubMed ID: 15895431 [TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity. Wu J; Aluko RE J Pept Sci; 2007 Jan; 13(1):63-9. PubMed ID: 17117396 [TBL] [Abstract][Full Text] [Related]
5. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity. Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648 [TBL] [Abstract][Full Text] [Related]
6. A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides. Sagardia I; Roa-Ureta RH; Bald C Food Chem; 2013 Feb; 136(3-4):1370-6. PubMed ID: 23194537 [TBL] [Abstract][Full Text] [Related]
7. Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides. Wu J; Aluko RE; Nakai S J Agric Food Chem; 2006 Feb; 54(3):732-8. PubMed ID: 16448176 [TBL] [Abstract][Full Text] [Related]
8. Quantitative sequence-activity model analysis of oligopeptides coupling an improved high-dimension feature selection method with support vector regression. Wang L; Dai Z; Zhang H; Bai L; Yuan Z Chem Biol Drug Des; 2014 Apr; 83(4):379-91. PubMed ID: 24125163 [TBL] [Abstract][Full Text] [Related]
9. Bradykinin analogs as inhibitors of angiotensin-converting enzyme. Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848 [TBL] [Abstract][Full Text] [Related]
10. [New 3D amino acid structure descriptors and its application to the polypeptide QSAR]. Ding JJ; Ding XQ; Zhao LF; Chen JS Yao Xue Xue Bao; 2005 Apr; 40(4):340-6. PubMed ID: 16011263 [TBL] [Abstract][Full Text] [Related]
11. SVEEVA descriptor application to peptide QSAR. Tong J; Che T; Liu S; Li Y; Wang P; Xu X; Chen Y Arch Pharm (Weinheim); 2011 Nov; 344(11):719-25. PubMed ID: 21956614 [TBL] [Abstract][Full Text] [Related]
12. Classification-based QSAR Models for the Prediction of the Bioactivity of ACE-inhibitor Peptides. Tripaldi P; Pérez-González A; Rojas C; Radax J; Ballabio D; Todeschini R Protein Pept Lett; 2018; 25(11):1015-1023. PubMed ID: 30430931 [TBL] [Abstract][Full Text] [Related]
14. Predicting the activity of ACE inhibitory peptides with a novel mode of pseudo amino acid composition. Shu M; Cheng X; Zhang Y; Wang Y; Lin Y; Wang L; Lin Z Protein Pept Lett; 2011 Dec; 18(12):1233-43. PubMed ID: 21728992 [TBL] [Abstract][Full Text] [Related]
15. New descriptors of amino acids and their application to peptide QSAR study. Lin ZH; Long HX; Bo Z; Wang YQ; Wu YZ Peptides; 2008 Oct; 29(10):1798-805. PubMed ID: 18606203 [TBL] [Abstract][Full Text] [Related]
16. ST-scale as a novel amino acid descriptor and its application in QSAM of peptides and analogues. Yang L; Shu M; Ma K; Mei H; Jiang Y; Li Z Amino Acids; 2010 Mar; 38(3):805-16. PubMed ID: 19373543 [TBL] [Abstract][Full Text] [Related]
17. Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides. Liang G; Yang L; Kang L; Mei H; Li Z Amino Acids; 2009 Oct; 37(4):583-91. PubMed ID: 18821054 [TBL] [Abstract][Full Text] [Related]
18. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
19. New Quantitative Structure-Activity Relationship Model for Angiotensin-Converting Enzyme Inhibitory Dipeptides Based on Integrated Descriptors. Deng B; Ni X; Zhai Z; Tang T; Tan C; Yan Y; Deng J; Yin Y J Agric Food Chem; 2017 Nov; 65(44):9774-9781. PubMed ID: 28984136 [TBL] [Abstract][Full Text] [Related]
20. Modeling dipeptides as ACE inhibitors and bitter-tasting compounds by means of E-state structure-information representation. Spasov B; Hall LH Chem Biodivers; 2007 Nov; 4(11):2528-39. PubMed ID: 18027352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]